GABRIEL LOPEZ to Antibodies, Monoclonal
This is a "connection" page, showing publications GABRIEL LOPEZ has written about Antibodies, Monoclonal.
Connection Strength
0.157
-
The potential of drug-carrying immunoliposomes as anticancer agents. Commentary re: J. W. Park et al., Anti-HER2 immunoliposomes: enhanced efficacy due to targeted delivery. Clin. Cancer Res., 8: 1172-1181, 2002. Clin Cancer Res. 2002 Apr; 8(4):955-6.
Score: 0.081
-
Biologic and immunomodulatory events after CTLA-4 blockade with ticilimumab in patients with advanced malignant melanoma. Cancer. 2006 Jun 01; 106(11):2437-44.
Score: 0.027
-
Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206. J Clin Oncol. 2005 Dec 10; 23(35):8968-77.
Score: 0.026
-
Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012 Feb 16; 366(7):610-8.
Score: 0.010
-
Centrifugal elutriation as a method for isolation of large numbers of functionally intact human peripheral blood monocytes. J Clin Apher. 1986; 3(2):111-8.
Score: 0.007
-
Specificity of BCR-ABL antisense oligonucleotides. Blood. 1995 Jan 15; 85(2):597-8.
Score: 0.006